ישראל - עברית - Ministry of Health

bayer israel ltd - cyproterone acetate - טבליה - cyproterone acetate 50 mg - cyproterone

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - abiraterone acetate - טבליה - abiraterone acetate 250 mg - abiraterone

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - abiraterone acetate - טבליה - abiraterone acetate 250 mg - abiraterone

ישראל - עברית - Ministry of Health

bioavenir ltd, israel - abiraterone acetate - טבליה - abiraterone acetate 250 mg - abiraterone

ישראל - עברית - Ministry of Health

dexcel ltd, israel - prasterone - prasterone 6.5 mg - prasterone

ישראל - עברית - Ministry of Health

taro international ltd, israel - abiraterone acetate - טבליה - abiraterone acetate 125 mg - abiraterone

ישראל - עברית - Ministry of Health

taro international ltd, israel - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 0.035 mg; cyproterone acetate 2 mg - for the treatment of signs of androgenization in women such as pronounced forms of acne, androgenic alopecia and mild forms of hirsutism.

ישראל - עברית - Ministry of Health

taro international ltd, israel - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 0.035 mg; cyproterone acetate 2 mg

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - טבליות בשחרור איטי - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - טבליות מצופות - clomipramine hydrochloride 25 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.